沙門氏/志賀氏菌雙通道核酸檢測(cè)試劑盒

廣州健侖生物科技有限公司

廣州健侖長(zhǎng)期供應(yīng)各種流感檢測(cè)試劑，包括進(jìn)口和國(guó)產(chǎn)的品牌，主要包括日本富士瑞必歐、日本生研、美國(guó)BD、美國(guó)NovaBios、美國(guó)binaxNOW、凱必利、廣州創(chuàng)侖等。

產(chǎn)品名稱：沙門氏/志賀氏菌雙通道核酸檢測(cè)試劑盒；

 產(chǎn)品品牌：創(chuàng)侖；

 產(chǎn)品用途：本PCR-熒光探針法體外定性檢測(cè)沙門氏/志賀氏菌雙通道核酸；

 產(chǎn)品規(guī)格：48T/盒； 

 保存條件：避光 -20度 保存。

    我司還提供各種流感病毒、副流感病毒、呼吸道合胞病毒、冠狀病毒、輪狀病毒、桿菌、鏈球菌、熱帶病毒等等核酸檢測(cè)試劑盒（PCR-熒光探針法），隨時(shí)歡迎您的來電

歡迎咨詢

歡迎咨詢2042552662

想了解更多的產(chǎn)品及服務(wù)請(qǐng)掃描下方二維碼：

【公司名稱】 廣州健侖生物科技有限公司
【市場(chǎng)部】    楊永漢

【】 
【騰訊  】 2042552662
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-103室

以下是我司提供的部分PCR產(chǎn)品

來自牛津大學(xué)的研究人員通過研究表示，利用5分鐘快速檢測(cè)法或許就可以降低治療呼吸道感染的抗生素濫用現(xiàn)象，而且降低不必要的抗生素使用是目前*抑制抗生素耐藥感染的關(guān)鍵方法，相關(guān)研究刊登于雜志The Lancet Global Health上。

這種快速檢測(cè)方法可以檢測(cè)患者血液中的C反應(yīng)蛋白（CRP），CRP是細(xì)菌引發(fā)感染的標(biāo)志物，低水平的CRP可以提示機(jī)體的病毒感染，從而就使得抗生素療法或許就并不需要進(jìn)行了。文章中研究者在越南河內(nèi)的10個(gè)主要的健康護(hù)理中心進(jìn)行這項(xiàng)測(cè)試，同時(shí)研究者還對(duì)隨機(jī)對(duì)檢測(cè)或未檢測(cè)CRP的2000名患者的抗生素使用記錄進(jìn)行了分析，結(jié)果表明，雖然患者臨床恢復(fù)相同，但成年人和兒童的抗生素的使用情況也會(huì)發(fā)生明顯地下降，這項(xiàng)試驗(yàn)中研究者*對(duì)資源匱乏地區(qū)的人群進(jìn)行了調(diào)查，而且調(diào)查結(jié)果同歐洲進(jìn)行的試驗(yàn)結(jié)果相似，而且這項(xiàng)試驗(yàn)是*對(duì)兒童進(jìn)行的CRP評(píng)估試驗(yàn)。

越南是*十四個(gè)經(jīng)濟(jì)快速發(fā)展的國(guó)家，抗生素的無監(jiān)管使用使得越南人對(duì)抗生素的耐藥性異常敏感；而且感染性疾病依然是引發(fā)越南人死亡的主要原因，抗生素耐藥性可以抵抗許多治療感染性疾病的療法；2014年WHO數(shù)據(jù)顯示，社區(qū)和醫(yī)院常見細(xì)菌的抗生素耐藥性已經(jīng)達(dá)到了*預(yù)警的水平了，因此開發(fā)快速診斷技術(shù)，降低不必要抗生素的使用或許是抵御抗生素耐藥性的一種*的方法。

研究者認(rèn)為，隨著多個(gè)新型商業(yè)化的CRP測(cè)試技術(shù)被評(píng)估可用，新型的干預(yù)措施或?qū)⒈贿M(jìn)一步擴(kuò)大，目前不同健康中心的干預(yù)措施所引發(fā)的效應(yīng)差異較大，研究者Nguyen Van Kinh說道，在簡(jiǎn)便易用工具的幫助下，健康服務(wù)供應(yīng)者就可以安全限制治療病毒性呼吸道感染的不必要抗生素的使用了，本文研究也為如何有效進(jìn)行抗生素的有效管理提供了簡(jiǎn)單的解決方法，為了大規(guī)模實(shí)現(xiàn)研究者的愿望，未來研究中他們將會(huì)評(píng)估所需的干預(yù)措施的成本效益，而相關(guān)的試驗(yàn)結(jié)果也將為進(jìn)行深入研究提供重要的數(shù)據(jù)支持。

Researchers from the University of Oxford through the study said, using 5 minutes fast detection method could reduce the overuse of antibiotics in treatment of respiratory tract infection, and reduce the unnecessary use of antibiotics is currently the world inhibit key methods of antibiotic resistant infections, related research published in the International Journal of The Lancet Global Health.

This rapid detection method can detect C reactive protein (CRP) in patients' blood. CRP is a marker of bacterial infection. Low level CRP can prompt viral infection of the body, so that antibiotic therapy may not need to be done. The researchers conducted the test in 10 primary health care center of Hanoi in Vietnam, at the same time, the researchers also randomly to detect or not detected CRP 2000 patients using antibiotics records were analyzed. The results show that although the clinical use of the same recovery, but adults and children are antibiotics will obviously decline for the first time in this pilot study conducted a survey on the resource poor areas of population, and the survey results were similar with Europe, and this is the first test of children's CRP assessment test.

Vietnam is the world's fourteenth rapid economic development of the country, no regulation makes use of Vietnamese resistance to antibiotics sensitive antibiotics; and infectious diseases are still the leading cause of death in Vietnamese, antibiotic resistance can resist many treatment of infectious diseases treatment; the 2014 WHO data show that the drug resistance of common bacteria and community hospital antibiotics have reached the world warning level, so the development of rapid diagnostic technology, reduce the unnecessary use of antibiotics may be one of the best ways to resist antibiotic resistance.

Researchers believe that with the CRP testing of a number of new commercial evaluation of novel interventions available, or will be further expanded, the effect of different differences between the current health center interventions caused by the larger Nguyen Van Kinh, said the researchers, in an easy to use tool for help, health service providers can use unnecessary antibiotic safety limit treatment of viral respiratory infection. The study also provides a simple solution for the effective management of how effective antibiotics, in order to achieve large-scale researchers desire, cost-effective interventions needed for future they will review studies, and test results will also be for further studies provide important data support.